Strides Pharma obtains FDA nod for generic Fioricet 

Sandra Levy
Senior Editor
Sandra Levy profile picture

The Food and Drug Administration has cleared Strides Pharma’s butalbital, acetaminophen, caffeine, and codeine phosphate capsules.

Strides' product is a generic of Teva’s Fioricet with Codeine capsules, 50 mg/325 mg/40 mg/30 mg. It is indicated for the treatment of the symptoms of complex tension (or muscle contraction) headache.

The product has a market value of roughly $10 million, according to IQVIA May 2020 data.